Advanced in Otitis

Xavier Llorens-Saez

Panama, PA 
Advanced in Otitis
Panama, PA 
OverviewLocationsClinical Research

Overview

Xavier Llorens-Saez practices in Panama, Panama. Mr. Llorens-Saez is rated as an Advanced expert by MediFind in the treatment of Otitis. His top areas of expertise are Poliomyelitis, Myelitis, Dengue Fever, and Viral Hemorrhagic Fever.

His clinical research consists of co-authoring 74 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Otitis.

Gender
Male

Locations

Panama, Panama
Other Locations
Av. 3a Oeste, Calle 33, Calidonia, Panama
Senacyt, Panama

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2b, Double-blind, Randomized, Multi-site, Placebo-controlled Trial to Evaluate the Efficacy, Safety and Immunogenicity of Intramuscular HIL-214 Norovirus Vaccine in Healthy Children 5 Months of Age at Initial Vaccination
A Phase 2b, Double-blind, Randomized, Multi-site, Placebo-controlled Trial to Evaluate the Efficacy, Safety and Immunogenicity of Intramuscular HIL-214 Norovirus Vaccine in Healthy Children 5 Months of Age at Initial Vaccination
Enrollment Status: Terminated
Publish Date: July 10, 2025
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
A Phase II/III Adaptive Seamless Design, Randomized, Controlled Trial To Evaluate Safety And Immunogenicity of 2 Dose-Regimen of BBV87 Chikungunya Vaccine In Healthy Subjects Aged 12 to 65 Years in Latin America and Asia.
A Phase II/III Adaptive Seamless Design, Randomized, Controlled Trial To Evaluate Safety And Immunogenicity of 2 Dose-Regimen of BBV87 Chikungunya Vaccine In Healthy Subjects Aged 12 to 65 Years in Latin America and Asia.
Enrollment Status: Terminated
Publish Date: June 22, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in Infants
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

74 Total Publications

Advancing respiratory syncytial virus (RSV) prevention in Latin America: updated recommendations from the Pediatric Infectious Diseases society of Latin America (SLIPE) expert group on RSV prevention.
Advancing respiratory syncytial virus (RSV) prevention in Latin America: updated recommendations from the Pediatric Infectious Diseases society of Latin America (SLIPE) expert group on RSV prevention.
Journal: Expert review of vaccines
Published: June 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Llorens-Saez's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile